Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Cediranib Maleate

Cediranib Maleate

Cediranib Maleate structure

Cediranib Maleate 

structure

Description

Cediranib maleate (AZD-2171 maleate) is a highly potent, orally available VEGFR inhibitor with IC50s of <1, <3, 5, 5, 36, 2 nM for Flt1, KDR, Flt4, PDGFRα, PDGFRβ, c-Kit, respectively.


Cediranib Maleate is the maleate salt of an indole ether quinazoline derivative with antineoplastic activities. Competing with adenosine triphosphate, cediranib binds to and inhibits all three vascular endothelial growth factor receptor (VEGFR-1,-2,-3) tyrosine kinases, thereby blocking VEGF-signaling, angiogenesis, and tumor cell growth.

Cediranib Maleate Basic Attributes

566.586

566.21800

68AYS9A614

732208

C48379

Characteristics

147

4.87390

198.3-200.08 °C (polymorph)

Safety Information

P201, P202, P260, P264, P270, P273, P281, P301+P310, P308+P313, P314, P321, P330, P391, P405, P501

H301

Drug Information

Treatment of high-grade glioma

Cediranib Maleate Use and Manufacturing

Uses

Cediranib (AZD2171) inhibited VEGF-stimulated proliferation and KDR phosphorylation with IC50 of 0.4 and 0.5 nM, respectively.

Human Drugs -> EU pediatric investigation plans

Computed Properties

Molecular Weight:566.6
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:11
Rotatable Bond Count:10
Exact Mass:566.21767750
Monoisotopic Mass:566.21767750
Topological Polar Surface Area:147
Heavy Atom Count:41
Complexity:743
Defined Bond Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.